Table 2.

Factors associated with pulmonary artery systolic pressure at least 30 mmHg in HIV-infected participants.

Parameter	Unadjusted Prevalence ratio (95% CI), P value	Fully adjusted Prevalence ratio (95% CI), P value
ADMA (per 0.1 μmol/l increase)	1.19 (1.01, 1.42), P =0.043	1.13 (0.94, 1.35), P =0.20
Age (per decade)	1.11 (0.92, 1.33), P =0.28	1.13 (0.92, 1.38), P =0.25
Female vs. male	1.36 (0.90, 2.1), P =0.15	1.10 (0.68, 1.78), P =0.69
African–American vs. white	1.40 (0.96, 2.1), P =0.080	1.24 (0.80, 1.91), P =0.33
Other/Latino vs. white	1.24 (0.75, 2.0), P =0.40	1.23 (0.73, 2.1), P =0.44
IVDU (current vs. never)	1.85 (1.09, 3.1), P =0.022	1.48 (0.73, 3.0), P =0.28
IVDU (past vs. never)	1.33 (0.91, 1.96), P =0.15	1.31 (0.81, 2.1), P =0.27
Cigarette smoking (current vs. never)	1.39 (0.92, 2.1), P =0.11	1.06 (0.65, 1.73), P =0.80
Cigarette smoking (past vs. never)	1.04 (0.66, 1.64), P =0.87	0.99 (0.61, 1.62), P =0.98
Stimulant use (current vs. never)	1.36 (0.86, 2.1), P =0.19	0.97 (0.53, 1.80), P =0.93
Stimulant use (past vs. never)	0.99 (0.66, 1.47), P =0.95	0.77 (0.48, 1.24), P =0.28
hsCRP (per doubling)	1.05 (0.95, 1.15), P =0.32	1.01 (0.91, 1.12), P =0.91
D-dimer (per doubling)	1.14 (1.00, 1.30), P =0.044	1.04 (0.89, 1.22), P =0.60
IL-6 (per doubling)	1.19 (1.05, 1.34), P =0.0057	1.10 (0.95, 1.29), P =0.20

Analysis includes all 214 HIV-infected participants; prevalence of outcome was 59.8% (128 of 214 participants). Multiple imputation was used to handle missing covariates: CRP (N =181), D-dimer (N =170), and IL-6 (N =164). ADMA, asymmetric dimethylarginine; CI, confidence interval; IVDU, intravenous drug use; PASP, pulmonary artery systolic pressure; PR, prevalence ratio.